Johns Hopkins and Eisai Extend Drug Discovery Collaboration with New Licensing Agreement

Reading Time: 1 minutes

The Johns Hopkins University and Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo, Japan-based Eisai Co., Ltd., announced today that they have extended their drug discovery collaboration through an exclusive licensing agreement.

Leave a Reply

Your email address will not be published. Required fields are marked *